InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Leversage Jill, Director. Insider active across 1 companies, notably Aurinia Pharmaceuticals Inc.. Cumulatively, 4 filings have been recorded. Total volume traded: €102k. The latest transaction was filed on 13 December 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations4 total
€28,3461,600 shares@ €17.71655.7% of flow
Common Stock
SEC:0001628280-21-025130·
Ideal exit: 9 Sept 2022 (T+270)
€28,3461,600 shares@ €17.7160.0013% mcap27.8% of flow
Common Stock
SEC:0001628280-21-025130:0·
Ideal exit: 9 Sept 2022 (T+270)
€22,5532,500 shares@ €9.021144.3% of flow
Common Stock
SEC:0001628280-21-010018·
Ideal exit: 5 Feb 2022 (T+270)
€22,5532,500 shares@ €9.02110.0011% mcap22.2% of flow
Common Stock
SEC:0001628280-21-010018:0·
Ideal exit: 5 Feb 2022 (T+270)
4 of 4 declarations
About Leversage Jill
Jill Leversage is a Board Member at Aurinia Pharmaceuticals Inc. She plays a key role in the governance of the company and in strategic decision-making. Her expertise in the pharmaceutical sector is valuable to the board.
